Video Experimental Relacionado

Updated: Mar 18, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Protocolo basado en químicos cuánticos para el diseño racional de inhibidores covalentes

Tanja Schirmeister¹, Jochen Kesselring¹, Sascha Jung¹

¹Institut für Pharmazie und Biochemie, Johannes Gutenberg Universität Mainz , Staudinger Weg 5, 55128 Mainz, Germany.

Journal of the American Chemical Society

|June 28, 2016

Resumen

Desarrollamos un método basado en la estructura para diseñar inhibidores covalentes personalizados. Este enfoque utiliza la mecánica cuántica y las simulaciones moleculares para seleccionar ojivas óptimas y optimizar las unidades de reconocimiento, creando con éxito inhibidores para la rodesaína.

Área de la Ciencia:

Química computacional
Descubrimiento de drogas
Modelado molecular

Sus antecedentes:

Los inhibidores covalentes ofrecen un potencial terapéutico único, pero requieren un diseño preciso.
El diseño de fármacos basado en la estructura es crucial para el desarrollo de terapias dirigidas.
Optimizar tanto la ojiva reactiva como la unidad de reconocimiento es clave.

Objetivo del estudio:

Presentar un nuevo protocolo basado en la estructura para diseñar inhibidores covalentes personalizados.
Para demostrar la precisión del protocolo en la predicción de las propiedades inhibidoras.
Aplicar el protocolo para el desarrollo de nuevos inhibidores contra la rodesaína.

Principales métodos:

Utilizando cálculos mecánicos cuánticos (QM) para la selección de sustitutos de ojivas.
El uso de enfoques híbridos MQ/mecánica molecular (MQ/MM) para cálculos avanzados.
Aplicando acoplamiento molecular para optimizar la unidad de reconocimiento del inhibidor.
Validación de las predicciones mediante simulaciones QM/MM o dinámicas moleculares (DM).

Principales resultados:

El protocolo guió con éxito la selección de sustitutos apropiados para ojivas covalentes.
El acoplamiento molecular optimizó efectivamente las unidades de reconocimiento para la formación de complejos no covalentes.
Las predicciones computacionales se validaron a través de simulaciones QM/MM y MD.
El enfoque demostró precisión en la identificación de candidatos inhibidores prometedores y la exclusión de los no prometedores.

Conclusiones:

El protocolo basado en la estructura propuesto permite el diseño preciso de inhibidores covalentes personalizados.
El método es eficaz para optimizar tanto la ojiva reactiva como los elementos de reconocimiento.
Este enfoque facilita el desarrollo de inhibidores covalentes dirigidos, como se muestra en el ejemplo de la rodesaína.

Más Videos Relacionados

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Videos de Conceptos Relacionados

MO Theory and Covalent Bonding

MO Theory and Covalent Bonding

The molecular orbital theory describes the distribution of electrons in molecules in a manner similar to the distribution of electrons in atomic orbitals. The region of space in which a valence electron in a molecule is likely to be found is called a molecular orbital. Mathematically, the linear combination of atomic orbitals (LCAO) generates molecular orbitals. Combinations of in-phase atomic orbital wave functions result in regions with a high probability of electron density, while...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Valence Bond Theory

Valence Bond Theory

Coordination compounds and complexes exhibit different colors, geometries, and magnetic behavior, depending on the metal atom/ion and ligands from which they are composed. In an attempt to explain the bonding and structure of coordination complexes, Linus Pauling proposed the valence bond theory, or VBT, using the concepts of hybridization and the overlapping of the atomic orbitals. According to VBT, the central metal atom or ion (Lewis acid) hybridizes to provide empty orbitals of suitable...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...